223 related articles for article (PubMed ID: 30745338)
1. Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency.
Han M; Napier CE; Frölich S; Teber E; Wong T; Noble JR; Choi EHY; Everett RD; Cesare AJ; Reddel RR
J Cell Sci; 2019 Mar; 132(5):. PubMed ID: 30745338
[TBL] [Abstract][Full Text] [Related]
2. Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.
Hou W; Cruz-Cosme R; Wen F; Ahn JH; Reeves I; Luo MH; Tang Q
J Virol; 2018 Dec; 92(23):. PubMed ID: 30258013
[TBL] [Abstract][Full Text] [Related]
3. Distinct temporal roles for the promyelocytic leukaemia (PML) protein in the sequential regulation of intracellular host immunity to HSV-1 infection.
Alandijany T; Roberts APE; Conn KL; Loney C; McFarlane S; Orr A; Boutell C
PLoS Pathog; 2018 Jan; 14(1):e1006769. PubMed ID: 29309427
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of the Replication of ICP0-Null Mutant Herpes Simplex Virus 1 and pp71-Deficient Human Cytomegalovirus by Epstein-Barr Virus Tegument Protein BNRF1.
Lu Y; Orr A; Everett RD
J Virol; 2016 Nov; 90(21):9664-9673. PubMed ID: 27535048
[TBL] [Abstract][Full Text] [Related]
5. PML plays both inimical and beneficial roles in HSV-1 replication.
Xu P; Mallon S; Roizman B
Proc Natl Acad Sci U S A; 2016 May; 113(21):E3022-8. PubMed ID: 27162364
[TBL] [Abstract][Full Text] [Related]
6. The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection.
Cuchet-Lourenço D; Anderson G; Sloan E; Orr A; Everett RD
J Virol; 2013 Dec; 87(24):13422-32. PubMed ID: 24089555
[TBL] [Abstract][Full Text] [Related]
7. Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis.
Cohen C; Corpet A; Roubille S; Maroui MA; Poccardi N; Rousseau A; Kleijwegt C; Binda O; Texier P; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2018 Sep; 14(9):e1007313. PubMed ID: 30235352
[TBL] [Abstract][Full Text] [Related]
8. A Tale of Two PMLs: Elements Regulating a Differential Substrate Recognition by the ICP0 E3 Ubiquitin Ligase of Herpes Simplex Virus 1.
Zheng Y; Samrat SK; Gu H
J Virol; 2016 Dec; 90(23):10875-10885. PubMed ID: 27681131
[TBL] [Abstract][Full Text] [Related]
9. PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.
Cuchet D; Sykes A; Nicolas A; Orr A; Murray J; Sirma H; Heeren J; Bartelt A; Everett RD
J Cell Sci; 2011 Jan; 124(Pt 2):280-91. PubMed ID: 21172801
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Response of IFI16 and Promyelocytic Leukemia Nuclear Body Components to Herpes Simplex Virus 1 Infection.
Everett RD
J Virol; 2016 Jan; 90(1):167-79. PubMed ID: 26468536
[TBL] [Abstract][Full Text] [Related]
11. MORC3, a Component of PML Nuclear Bodies, Has a Role in Restricting Herpes Simplex Virus 1 and Human Cytomegalovirus.
Sloan E; Orr A; Everett RD
J Virol; 2016 Oct; 90(19):8621-33. PubMed ID: 27440897
[TBL] [Abstract][Full Text] [Related]
12. HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons.
Catez F; Picard C; Held K; Gross S; Rousseau A; Theil D; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2012; 8(8):e1002852. PubMed ID: 22912575
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus is equipped with RNA- and protein-based mechanisms to repress expression of ATRX, an effector of intrinsic immunity.
Jurak I; Silverstein LB; Sharma M; Coen DM
J Virol; 2012 Sep; 86(18):10093-102. PubMed ID: 22787211
[TBL] [Abstract][Full Text] [Related]
14. The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem.
Gu H; Roizman B
J Virol; 2009 Jan; 83(1):181-7. PubMed ID: 18945770
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx.
Lukashchuk V; Everett RD
J Virol; 2010 Apr; 84(8):4026-40. PubMed ID: 20147399
[TBL] [Abstract][Full Text] [Related]
16. PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.
Sobol PT; Hummel JL; Rodrigues RM; Mossman KL
Gene Ther; 2009 Sep; 16(9):1077-87. PubMed ID: 19474810
[TBL] [Abstract][Full Text] [Related]
17. The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1.
Wang S; Long J; Zheng CF
Protein Cell; 2012 May; 3(5):372-82. PubMed ID: 22544561
[TBL] [Abstract][Full Text] [Related]
18. Identification of three redundant segments responsible for herpes simplex virus 1 ICP0 to fuse with ND10 nuclear bodies.
Zheng Y; Gu H
J Virol; 2015 Apr; 89(8):4214-26. PubMed ID: 25631093
[TBL] [Abstract][Full Text] [Related]
19. STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts.
Everett RD; Young DF; Randall RE; Orr A
J Virol; 2008 Sep; 82(17):8871-81. PubMed ID: 18579584
[TBL] [Abstract][Full Text] [Related]
20. Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment.
Maroui MA; Callé A; Cohen C; Streichenberger N; Texier P; Takissian J; Rousseau A; Poccardi N; Welsch J; Corpet A; Schaeffer L; Labetoulle M; Lomonte P
PLoS Pathog; 2016 Sep; 12(9):e1005834. PubMed ID: 27618691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
